ID   DGKG_RAT                Reviewed;         788 AA.
AC   P49620;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   29-MAY-2024, entry version 168.
DE   RecName: Full=Diacylglycerol kinase gamma;
DE            Short=DAG kinase gamma;
DE            EC=2.7.1.107 {ECO:0000269|PubMed:7809169};
DE   AltName: Full=88 kDa diacylglycerol kinase;
DE   AltName: Full=DGK-III {ECO:0000303|PubMed:7809169};
DE   AltName: Full=Diglyceride kinase gamma;
DE            Short=DGK-gamma;
GN   Name=Dgkg; Synonyms=Dagk3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, PATHWAY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar;
RX   PubMed=7809169; DOI=10.1073/pnas.91.26.13042;
RA   Goto K., Funayama M., Kondo H.;
RT   "Cloning and expression of a cytoskeleton-associated diacylglycerol kinase
RT   that is dominantly expressed in cerebellum.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:13042-13046(1994).
CC   -!- FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into
CC       phosphatidic acid/phosphatidate/PA and regulates the respective levels
CC       of these two bioactive lipids (PubMed:7809169). Thereby, acts as a
CC       central switch between the signaling pathways activated by these second
CC       messengers with different cellular targets and opposite effects in
CC       numerous biological processes (By similarity). Has no apparent
CC       specificity with regard to the acyl compositions of diacylglycerol (By
CC       similarity). Specifically expressed in the cerebellum where it controls
CC       the level of diacylglycerol which in turn regulates the activity of
CC       protein kinase C gamma. Through protein kinase C gamma, indirectly
CC       regulates the dendritic development of Purkinje cells, cerebellar long
CC       term depression and ultimately cerebellar motor coordination (By
CC       similarity). {ECO:0000250|UniProtKB:P49619,
CC       ECO:0000250|UniProtKB:Q91WG7, ECO:0000269|PubMed:7809169}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + ATP = a 1,2-diacyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:10272, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:30616, ChEBI:CHEBI:58608,
CC         ChEBI:CHEBI:456216; EC=2.7.1.107;
CC         Evidence={ECO:0000269|PubMed:7809169};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10273;
CC         Evidence={ECO:0000305|PubMed:7809169};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-didecanoyl-sn-glycerol + ATP = 1,2-didecanoyl-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:43428, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:18155, ChEBI:CHEBI:30616, ChEBI:CHEBI:78227,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:7809169};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43429;
CC         Evidence={ECO:0000305|PubMed:7809169};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + ATP = 1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40327, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:74546, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:7809169};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40328;
CC         Evidence={ECO:0000305|PubMed:7809169};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z,12Z)-octadecadienoyl-sn-glycerol + ATP =
CC         1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate +
CC         ADP + H(+); Xref=Rhea:RHEA:40339, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:77097, ChEBI:CHEBI:77098,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:7809169};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40340;
CC         Evidence={ECO:0000305|PubMed:7809169};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + ATP = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:40323, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:75728, ChEBI:CHEBI:77091,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:7809169};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40324;
CC         Evidence={ECO:0000305|PubMed:7809169};
CC   -!- ACTIVITY REGULATION: The activity is calcium-dependent
CC       (PubMed:7809169). Requires phosphatidylserine for maximal activity (By
CC       similarity). {ECO:0000250|UniProtKB:P49619,
CC       ECO:0000269|PubMed:7809169}.
CC   -!- PATHWAY: Lipid metabolism; glycerolipid metabolism.
CC       {ECO:0000305|PubMed:7809169}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:7809169}. Cytoplasm,
CC       cytosol {ECO:0000250|UniProtKB:P49619}. Cytoplasm, cytoskeleton
CC       {ECO:0000305|PubMed:7809169}.
CC   -!- TISSUE SPECIFICITY: Expressed specifically in brain (PubMed:7809169).
CC       Highly expressed in cerebellar Purkinje cells (at protein level)
CC       (PubMed:7809169). {ECO:0000269|PubMed:7809169}.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38448; BAA07480.1; -; mRNA.
DR   RefSeq; NP_037258.1; NM_013126.1.
DR   AlphaFoldDB; P49620; -.
DR   BioGRID; 247695; 2.
DR   STRING; 10116.ENSRNOP00000002452; -.
DR   iPTMnet; P49620; -.
DR   PhosphoSitePlus; P49620; -.
DR   PaxDb; 10116-ENSRNOP00000002452; -.
DR   Ensembl; ENSRNOT00000002452.6; ENSRNOP00000002452.5; ENSRNOG00000001796.7.
DR   Ensembl; ENSRNOT00055007917; ENSRNOP00055005969; ENSRNOG00055004952.
DR   Ensembl; ENSRNOT00060019297; ENSRNOP00060015117; ENSRNOG00060011395.
DR   Ensembl; ENSRNOT00065005330; ENSRNOP00065003859; ENSRNOG00065003668.
DR   GeneID; 25666; -.
DR   KEGG; rno:25666; -.
DR   UCSC; RGD:2499; rat.
DR   AGR; RGD:2499; -.
DR   CTD; 1608; -.
DR   RGD; 2499; Dgkg.
DR   eggNOG; KOG1169; Eukaryota.
DR   GeneTree; ENSGT00940000156768; -.
DR   HOGENOM; CLU_003770_1_0_1; -.
DR   InParanoid; P49620; -.
DR   OMA; PKELKLC; -.
DR   OrthoDB; 4642163at2759; -.
DR   PhylomeDB; P49620; -.
DR   TreeFam; TF313104; -.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   UniPathway; UPA00230; -.
DR   PRO; PR:P49620; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001796; Expressed in adult mammalian kidney and 16 other cell types or tissues.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004143; F:ATP-dependent diacylglycerol kinase activity; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008289; F:lipid binding; ISO:RGD.
DR   GO; GO:0046339; P:diacylglycerol metabolic process; ISS:UniProtKB.
DR   GO; GO:0046486; P:glycerolipid metabolic process; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0046834; P:lipid phosphorylation; ISS:UniProtKB.
DR   GO; GO:0090038; P:negative regulation of protein kinase C signaling; ISS:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IEP:RGD.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; TAS:RGD.
DR   GO; GO:0050773; P:regulation of dendrite development; ISO:RGD.
DR   CDD; cd20892; C1_DGKgamma_rpt2; 1.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 2.60.200.40; -; 1.
DR   Gene3D; 3.30.60.20; -; 2.
DR   Gene3D; 1.10.238.110; Diacylglycerol kinase alpha; 2.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_N.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR047475; C1_DGKgamma_rpt2.
DR   InterPro; IPR029477; DAG_kinase_typeI_N.
DR   InterPro; IPR037607; DGK.
DR   InterPro; IPR038199; DGK_typeI_N_sf.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   PANTHER; PTHR11255; DIACYLGLYCEROL KINASE; 1.
DR   PANTHER; PTHR11255:SF36; DIACYLGLYCEROL KINASE GAMMA; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF14513; DAG_kinase_N; 1.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 2.
DR   SUPFAM; SSF47473; EF-hand; 2.
DR   SUPFAM; SSF111331; NAD kinase/diacylglycerol kinase-like; 1.
DR   PROSITE; PS50146; DAGK; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Calcium; Cytoplasm; Cytoskeleton; Kinase; Lipid metabolism;
KW   Membrane; Metal-binding; Nucleotide-binding; Reference proteome; Repeat;
KW   Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..788
FT                   /note="Diacylglycerol kinase gamma"
FT                   /id="PRO_0000218461"
FT   DOMAIN          172..207
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          217..252
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          427..561
FT                   /note="DAGKc"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   ZN_FING         268..318
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         333..380
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          83..150
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          768..788
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        94..110
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         185
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305"
FT   BINDING         187
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305"
FT   BINDING         189
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305"
FT   BINDING         196
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305"
FT   BINDING         230
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         234
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         241
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
SQ   SEQUENCE   788 AA;  88521 MW;  E77BCA40B22C1DA9 CRC64;
     MSDGQWVCLS SEEFDQLQKY SEYSSKKIKD VLAEFNEGGS LKQYDPHKPI SYDVFKLFMR
     AYLEVDLPQP LSTNLFLAFS QKPRQETPDH PKEGASSSEP NVSDSNAEST AKADAACAPD
     TESKPIKTQV PSEELEAAAP WGEPNAPASS SDAPIVYLKD VVCYLSLMET GRPQDKLEFM
     FRLYDSDENE LLDQAELDQI VSQMLHVAQY LEWDPTELRP ILKEMLQGMD YNKDGFVSLE
     EWVSGGMTTI PLLVLLGMDD SASKGDGRHA WTLKHFKKPT YCNFCHIMLM GVRKQGLCCI
     YCKYAVHQRC VSNSIPGCVK TYSKAKRSGE VMQHAWVEGN SSVKCDRCHK SIKCYQSVTA
     RHCVWCRMTF HRKCELSTAC DGGELKDHIL LPTSIYPVTR DRQAGKSDSG AAAKGELVMQ
     YKIIPSPGTH PLLVLVNPKS GGRQGERILQ KFHYLLNPKQ VFNLDKGGPT PGLNFFQDTP
     DFRVLACGGD GTVGWILDCI DKANFTKHPP VAVLPLGTGN DLARCLRWGG GYEGGSLTKI
     LKEIEQSPLV MLDRWYLEVM PREEVENGDQ VPYNIMNNYF SIGVDASIAH RFHVMREKHP
     EKFNSRMKNK LWYFEFGTSE TFAATCKKLH DHIELECDGV EVDLSNIFLE GIAILNIPSM
     YGGTNLWGET KKNRAVIRES RKSVTDPKEL KCCVQDLSDQ LLEVVGLEGA MEMGQIYTGL
     KSAGRRLAQC SSVTIRTKKL LPMQVDGEPW MQPPCMIKIT HKNQAPMMMG PPQKSSFFSL
     RRKSRSKD
//
